Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zincogut Plus
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Zincogut Plus is an oral nutraceutical supplement formulated as a tablet containing a combination of 12 vitamins, 9 minerals, and grape seed extract. Developed by Centaur Pharmaceuticals, it is designed to support immune function, combat micronutrient deficiencies, reduce fatigue, and aid in recovery during convalescence. The formulation includes essential vitamins (such as Vitamin A, B-complex, C, D2, and E), minerals (including Zinc, Magnesium, Copper, and Selenium), and grape seed extract, which collectively act as antioxidants, immunomodulators, and enzymatic co-factors.
- Brand names
- Zincogut Plus
- Other names
- Zincogut Plus Tablets
Beyond the preview
Go deeper on Zincogut Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zincogut Plus.